The upregulation of NEAT1 is reported to result in the targeted mediation of downstream miR-3194-5p to increase Galectin-7 expression, which subsequently inhibits the activity of psoriasis HaCat cells and exhibits therapeutic effects [52]. This evidence concerns the gene LGALS7 and psoriasis.